BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1780970)

  • 1. Light-induced racemization: artifacts in the analysis of the diastereoisomeric pairs of thioridazine 5-sulfoxide in the plasma and urine of patients treated with thioridazine.
    Eap CB; Souche A; Koeb L; Baumann P
    Ther Drug Monit; 1991 Jul; 13(4):356-62. PubMed ID: 1780970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the enantiomers of thioridazine, thioridazine 2-sulfone, and of the isomeric pairs of thioridazine 2-sulfoxide and thioridazine 5-sulfoxide in human plasma.
    Eap CB; Koeb L; Powell K; Baumann P
    J Chromatogr B Biomed Appl; 1995 Jul; 669(2):271-9. PubMed ID: 7581903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation and configurational changes of thioridazine 2-sulfoxide.
    de Gaitani CM; Martinez AS; Bonato PS
    J Pharm Biomed Anal; 2004 Nov; 36(3):601-7. PubMed ID: 15522536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racemization and degradation of thioridazine and thioridazine 2-sulfone in human plasma and aqueous solutions.
    Masetto de Gaitani C; Martinez AS; Bonato PS
    Chirality; 2003 Jun; 15(6):479-85. PubMed ID: 12774286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on thioridazine 5-sulfoxide epimerization and degradation by capillary electrophoresis.
    Masetto de Gaitani C; Martinez AS; Bonato PS
    Electrophoresis; 2003 Aug; 24(15):2723-30. PubMed ID: 12900889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective analysis of thioridazine-2-sulfoxide and thioridazine-5-sulfoxide: an investigation of rac-thioridazine biotransformation by some endophytic fungi.
    Borges KB; De Souza Borges W; Pupo MT; Bonato PS
    J Pharm Biomed Anal; 2008 Apr; 46(5):945-52. PubMed ID: 17614234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.
    Daniel WA; Syrek M; Mach A; Wójcikowski J; Boksa J
    Pol J Pharmacol; 1997; 49(6):439-52. PubMed ID: 9566048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of the enantiomers of thioridazine, thioridazine 2-sulfoxide, thioridazine 2-sulfone, and thioridazine 5-sulfoxide in poor and extensive metabolizers of dextromethorphan and mephenytoin.
    Eap CB; Guentert TW; Schãublin-Loidl M; Stabl M; Koeb L; Powell K; Baumann P
    Clin Pharmacol Ther; 1996 Mar; 59(3):322-31. PubMed ID: 8653995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption and excretion of thioridazine and mesoridazine in man.
    Charalampous KD; Johnson PC; Estevez V
    Dis Nerv Syst; 1974 Nov; 35(11):494-6. PubMed ID: 17896456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative anticholinergic properties of thioridazine, mesoridazine and sulforidazine.
    Niedzwiecki DM; Cubeddu LX; Mailman RB
    J Pharmacol Exp Ther; 1989 Jul; 250(1):126-33. PubMed ID: 2746492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artifacts in the analysis of thioridazine and other neuroleptics.
    Eap CB; Koeb L; Baumann P
    J Pharm Biomed Anal; 1993 Jun; 11(6):451-7. PubMed ID: 8104489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum.
    Niedzwiecki DM; Cubeddu LX; Mailman RB
    J Pharmacol Exp Ther; 1989 Jul; 250(1):117-25. PubMed ID: 2746491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients.
    Carrillo JA; Ramos SI; Herraiz AG; Llerena A; Agundez JA; Berecz R; Duran M; Benítez J
    J Clin Psychopharmacol; 1999 Dec; 19(6):494-9. PubMed ID: 10587283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioreceptor assay and high-performance liquid chromatography yield similar results for serum thioridazine and its major metabolites.
    Rao ML; Brown WA; Wagner R
    Ther Drug Monit; 1988; 10(2):184-7. PubMed ID: 3381236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioridazine 5-sulfoxide diastereoisomers in serum and urine from rats and man after chronic thioridazine administration.
    Hale PW; Poklis A
    J Anal Toxicol; 1985; 9(5):197-201. PubMed ID: 4057956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biotransformation of thioridazine to thioridazine 5-sulfoxide stereoisomers in phenobarbital induced rats.
    Hale PW; Poklis A
    Eur J Drug Metab Pharmacokinet; 1986; 11(4):283-9. PubMed ID: 3582423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    Pol J Pharmacol; 1998; 50(6):431-42. PubMed ID: 10385926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined ultraviolet-fluorescence detection in high-pressure liquid chromatography of pharmaceuticals.
    Lindner W; Frei RW; Santi W
    J Chromatogr; 1975 Sep; 111(2):365-71. PubMed ID: 1159014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulphoxide metabolites of thioridazine in man.
    Papadopoulos AS; Crammer JL
    Xenobiotica; 1986 Dec; 16(12):1097-107. PubMed ID: 3798957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma propranolol levels and their effect on plasma thioridazine and haloperidol concentrations.
    Greendyke RM; Kanter DR
    J Clin Psychopharmacol; 1987 Jun; 7(3):178-82. PubMed ID: 3597804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.